Article
Lysosomal alterations and decreased electrophysiological activity in CLN3 disease (966 bp…
medRxiv · 2022 · Chear, S.; Perry, S.; Wilson, R.; Bindoff, A.; Talbot, J.; Ware, T.; Grubman, A.; Vickers, J. C.; Pebay, A.; Ruddle, J. B.; King, A. E.; Hewitt, A. W.; Cook, A. L.
Key facts
| Title | Lysosomal alterations and decreased electrophysiological activity in CLN3 disease (966 bp deletion, E295K) patient-derived cortical neurons |
|---|---|
| First author | Chear, S.; Perry, S.; Wilson, R.; Bindoff, A.; Talbot, J.; Ware, T.; Grubman, A.; Vickers, J. C.; Pebay, A.; Ruddle, J. B.; King, A. E.; Hewitt, A. W.; Cook, A. L. |
| Journal | medRxiv |
| Published | Apr 29, 2022 |
| DOI | 10.1101/2022.04.28.489465 |
| Devices mentioned | K800781 |
| Product codes mentioned | KIS, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1